64Cu-SAR-bisPSMA Trial for Prostate Cancer
Phase 3
220
about 1.6 years
18+
Male only
24 sites in AR, AZ, CA +15
About this study
Researchers are testing whether 64Cu-SAR-bisPSMA can help find prostate cancer that has returned after treatment. The trial will involve men with prostate cancer who have had previous treatments like surgery, radiation, or brachytherapy. Participants will be followed for about a year and a half.
Based on ClinicalTrials.gov records.
What participants do
- 1.Take 64Cu-SAR-bisPSMA
Participation effort
Estimated from trial records. Details can vary by site.
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Secondary: To determine the efficacy of 64Cu-SAR-bisPSMA PET/CT in participants with negative or equivocal conventional imaging at baseline, To investigate the safety and tolerability of 64-CuSAR-bisPSMA
Oncology